NeoChord, Inc., a venture backed medical device company, is investigating minimally invasive technology intended to transform the treatment of degenerative mitral regurgitation.

Learn More

Latest Developments

• "NeoChord Enrolls First Patient in European Clinical Trial"
  October 28, 2009
• "Off-Pump Transapical Mitral Valve Repair"
  Autumn, 2011
• "NeoChord Raises At Least $2.8 million for Mitral Valve Repair Technology"
  July 6, 2009
• "Clarian Invests in Minnesota Technology Company"
  October 7, 2008
• "Minnetonka Firm to Test New Heart Valve Repair..."
  July 14, 2009
• "Start-up raises $1.2M for heart 'strings'"
  October 17, 2008
• "Mayo Clinic + Neochord"
  November 12, 2007